Unknown

Dataset Information

0

Constitutive Expression of a Dominant-Negative TGF-? Type II Receptor in the Posterior Left Atrium Leads to Beneficial Remodeling of Atrial Fibrillation Substrate.


ABSTRACT: Fibrosis is an important structural contributor to formation of atrial fibrillation (AF) substrate in heart failure. Transforming growth factor-? (TGF-?) signaling is thought to be intricately involved in creation of atrial fibrosis.We hypothesized that gene-based expression of dominant-negative type II TGF-? receptor (TGF-?-RII-DN) in the posterior left atrium in a canine heart failure model will sufficiently attenuate fibrosis-induced changes in atrial conduction and restitution to decrease AF. Because AF electrograms are thought to reflect AF substrate, we further hypothesized that TGF-?-RII-DN would lead to increased fractionation and decreased organization of AF electrograms.Twenty-one dogs underwent injection+electroporation in the posterior left atrium of plasmid expressing a dominant-negative TGF-? type II receptor (pUBc-TGF?-DN-RII; n=9) or control vector (pUBc-LacZ; n=12), followed by 3 to 4 weeks of right ventricular tachypacing (240 bpm). Compared with controls, dogs treated with pUBC-TGF?-DN-RII demonstrated an attenuated increase in conduction inhomogeneity, flattening of restitution slope and decreased duration of induced AF, with AF electrograms being more fractionated and less organized in pUBc-TGF?-DN-RII versus pUBc-LacZ dogs. Tissue analysis revealed a significant decrease in replacement/interstitial fibrosis, p-SMAD2/3 and p-ERK1/2.Targeted gene-based reduction of TGF-? signaling in the posterior left atrium-with resulting decrease in replacement fibrosis-led to beneficial remodeling of both conduction and restitution characteristics of the posterior left atrium, translating into a decrease in AF and increased complexity of AF electrograms. In addition to providing mechanistic insights, this data may have important diagnostic and therapeutic implications for AF.

SUBMITTER: Kunamalla A 

PROVIDER: S-EPMC4920729 | biostudies-literature | 2016 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Constitutive Expression of a Dominant-Negative TGF-β Type II Receptor in the Posterior Left Atrium Leads to Beneficial Remodeling of Atrial Fibrillation Substrate.

Kunamalla Aaron A   Ng Jason J   Parini Vamsi V   Yoo Shin S   McGee Kate A KA   Tomson Todd T TT   Gordon David D   Thorp Edward B EB   Lomasney Jon J   Zhang Qiang Q   Shah Sanjiv S   Browne Suzanne S   Knight Bradley P BP   Passman Rod R   Goldberger Jeffrey J JJ   Aistrup Gary G   Arora Rishi R  

Circulation research 20160523 1


<h4>Rationale</h4>Fibrosis is an important structural contributor to formation of atrial fibrillation (AF) substrate in heart failure. Transforming growth factor-β (TGF-β) signaling is thought to be intricately involved in creation of atrial fibrosis.<h4>Objective</h4>We hypothesized that gene-based expression of dominant-negative type II TGF-β receptor (TGF-β-RII-DN) in the posterior left atrium in a canine heart failure model will sufficiently attenuate fibrosis-induced changes in atrial condu  ...[more]

Similar Datasets

| S-EPMC5419517 | biostudies-literature
| S-EPMC3124959 | biostudies-literature
| S-EPMC6317307 | biostudies-literature
| S-EPMC6824299 | biostudies-literature
| S-EPMC3607326 | biostudies-literature
| S-EPMC8855127 | biostudies-literature
| S-EPMC3570566 | biostudies-literature
| S-EPMC11372619 | biostudies-literature
2020-11-14 | GSE161450 | GEO
| S-EPMC6780583 | biostudies-literature